A real short squeeze- Mannkind- up against adam feuerstein Zachs Bad Press Novartis etc but recc to Approve.!
The advisory committee just now voted for approval.The FDA doesn't necessarily have to follow( but usually does 90+%) Mannkind ( Mr Mann) has had a long hard road.Short % of Float (as of Mar 14, 2014)!!=41.70%.... the short interest I think has a wegie. Congrats 13 yes 1 no 1 abstain for Type1 for T2